Modulating innate immunity improves hepatitis C virus infection and replication in stem cell-derived hepatocytes

Stem Cell Reports

Volumn 3, Issue 1, 2014, Pages 204-214

  Zhou, Xiaoling ^a,b,c   Sun, Pingnan ^a,b,c   Lucendo Villarin, Baltasar ^b   Angus, Allan G N ^c   Szkolnicka, Dagmara ^b   Cameron, Kate ^b   Farnworth, Sarah L ^b   Patel, Arvind H ^c   Hay, David C ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 29; JANUS KINASE; JANUS KINASE INHIBITOR; STAT PROTEIN;

ARTICLE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENZYME INHIBITION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INNATE IMMUNITY; LIVER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS REPLICATION; CELL LINE; HEPACIVIRUS; IMMUNOLOGY; PATHOGENICITY; PHYSIOLOGY; STEM CELL; VIROLOGY;

HEPATITIS C VIRUS;

CELL LINE; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; STEM CELLS; VIRUS REPLICATION;

EID: 84904245935     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2014.04.018     Document Type: Article

References (39)

1. J. Cai, Y. Zhao, Y. Liu, F. Ye, Z. Song, H. Qin, S. Meng, Y. Chen, R. Zhou, and X. Song et al. Directed differentiation of human embryonic stem cells into functional hepatic cells Hepatology 45 2007 1229 1239 (Pubitemid 46775786)
2. N. Calland, A. Albecka, S. Belouzard, C. Wychowski, G. Duverlie, V. Descamps, D. Hober, J. Dubuisson, Y. Rouillé, and K. Séron (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry Hepatology 55 2012 720 729
3. D. Da Costa, M. Turek, D.J. Felmlee, E. Girardi, S. Pfeffer, G. Long, R. Bartenschlager, M.B. Zeisel, and T.F. Baumert Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells J. Virol. 86 2012 11919 11925
4. H. Dickensheets, F. Sheikh, O. Park, B. Gao, and R.P. Donnelly Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes J. Leukoc. Biol. 93 2013 377 385
5. Y. Duan, A. Catana, Y. Meng, N. Yamamoto, S. He, S. Gupta, S.S. Gambhir, and M.A. Zern Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo Stem Cells 25 2007 3058 3068 (Pubitemid 350294431)
6. M.J. Evans, T. von Hahn, D.M. Tscherne, A.J. Syder, M. Panis, B. Wölk, T. Hatziioannou, J.A. McKeating, P.D. Bieniasz, and C.M. Rice Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry Nature 446 2007 801 805 (Pubitemid 46582027)
7. E. Foy, K. Li, R. Sumpter Jr., Y.M. Loo, C.L. Johnson, C. Wang, P.M. Fish, M. Yoneyama, T. Fujita, S.M. Lemon, and M. Gale Jr. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling Proc. Natl. Acad. Sci. USA 102 2005 2986 2991 (Pubitemid 40299903)
8. Z. Hannoun, J. Fletcher, S. Greenhough, C. Medine, K. Samuel, R. Sharma, A. Pryde, J.R. Black, J.A. Ross, and I. Wilmut et al. The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation Cell Reprogram. 12 2010 133 140
9. D.C. Hay Rapid and scalable human stem cell differentiation: now in 3D Stem Cells Dev. 22 2013 2691 2692
10. D.C. Hay, J. Fletcher, C. Payne, J.D. Terrace, R.C. Gallagher, J. Snoeys, J.R. Black, D. Wojtacha, K. Samuel, and Z. Hannoun et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling Proc. Natl. Acad. Sci. USA 105 2008 12301 12306
11. D.C. Hay, S. Pernagallo, J.J. Diaz-Mochon, C.N. Medine, S. Greenhough, Z. Hannoun, J. Schrader, J.R. Black, J. Fletcher, and D. Dalgetty et al. Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism Stem Cell Res. (Amst.) 6 2011 92 102
12. S.M. Horner, and M. Gale Jr. Regulation of hepatic innate immunity by hepatitis C virus Nat. Med. 19 2013 879 888
13. M. Iro, J. Witteveldt, A.G. Angus, I. Woerz, A. Kaul, R. Bartenschlager, and A.H. Patel A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication Antiviral Res. 83 2009 148 155
14. H. Kato, O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, and K.J. Ishii et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses Nature 441 2006 101 105
15. S.V. Kotenko, G. Gallagher, V.V. Baurin, A. Lewis-Antes, M. Shen, N.K. Shah, J.A. Langer, F. Sheikh, H. Dickensheets, and R.P. Donnelly IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex Nat. Immunol. 4 2003 69 77 (Pubitemid 36109115)
16. Y. Liang, T. Shilagard, S.Y. Xiao, N. Snyder, D. Lau, L. Cicalese, H. Weiss, G. Vargas, and S.M. Lemon Visualizing hepatitis C virus infections in human liver by two-photon microscopy Gastroenterology 137 2009 1448 1458
17. B. Lucendo-Villarin, F. Khan, S. Pernagallo, M. Bradley, J.P. Iredale, and D.C. Hay The effect of biological and synthetic matrices on hepatic stem cell gene expression BioResearch Open Access 1 2012 50 53
18. C.N. Medine, B. Lucendo-Villarin, C. Storck, F. Wang, D. Szkolnicka, F. Khan, S. Pernagallo, J.R. Black, H.M. Marriage, and J.A. Ross et al. Developing high-fidelity hepatotoxicity models from pluripotent stem cells Stem Cells Transl. Med. 2 2013 505 509
19. H. Park, E. Serti, O. Eke, B. Muchmore, L. Prokunina-Olsson, S. Capone, A. Folgori, and B. Rehermann IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection Hepatology 56 2012 2060 2070
20. P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani Binding of hepatitis C virus to CD81 Science 282 1998 938 941 (Pubitemid 28507525)
21. A. Ploss, M.J. Evans, V.A. Gaysinskaya, M. Panis, H. You, Y.P. de Jong, and C.M. Rice Human occludin is a hepatitis C virus entry factor required for infection of mouse cells Nature 457 2009 882 886
22. A. Ploss, S.R. Khetani, C.T. Jones, A.J. Syder, K. Trehan, V.A. Gaysinskaya, K. Mu, K. Ritola, C.M. Rice, and S.N. Bhatia Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures Proc. Natl. Acad. Sci. USA 107 2010 3141 3145
23. P. Podevin, A. Carpentier, V. Pène, L. Aoudjehane, M. Carrière, S. Zaïdi, C. Hernandez, V. Calle, J.F. Méritet, and O. Scatton et al. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes Gastroenterology 139 2010 1355 1364
24. P. Roelandt, S. Obeid, J. Paeshuyse, J. Vanhove, A. Van Lommel, Y. Nahmias, F. Nevens, J. Neyts, and C.M. Verfaillie Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus J. Hepatol. 57 2012 246 251
25. C.E. Samuel Antiviral actions of interferons Clin. Microbiol. Rev. 14 2001 778 809 (Pubitemid 32979631)
26. E. Scarselli, H. Ansuini, R. Cerino, R.M. Roccasecca, S. Acali, G. Filocamo, C. Traboni, A. Nicosia, R. Cortese, and A. Vitelli The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus EMBO J. 21 2002 5017 5025
27. R.E. Schwartz, K. Trehan, L. Andrus, T.P. Sheahan, A. Ploss, S.A. Duncan, C.M. Rice, and S.N. Bhatia Modeling hepatitis C virus infection using human induced pluripotent stem cells Proc. Natl. Acad. Sci. USA 109 2012 2544 2548
28. K. Si-Tayeb, F.K. Noto, M. Nagaoka, J. Li, M.A. Battle, C. Duris, P.E. North, S. Dalton, and S.A. Duncan Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells Hepatology 51 2010 297 305
29. G.J. Sullivan, D.C. Hay, I.H. Park, J. Fletcher, Z. Hannoun, C.M. Payne, D. Dalgetty, J.R. Black, J.A. Ross, and K. Samuel et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells Hepatology 51 2010 329 335
30. R. Sumpter Jr., Y.M. Loo, E. Foy, K. Li, M. Yoneyama, T. Fujita, S.M. Lemon, and M. Gale Jr. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I J. Virol. 79 2005 2689 2699 (Pubitemid 40270547)
31. P. Sun, X. Zhou, S.L. Farnworth, A.H. Patel, and D.C. Hay Modeling human liver biology using stem cell-derived hepatocytes Int. J. Mol. Sci. 14 2013 22011 22021
32. D. Szkolnicka, W. Zhou, B. Lucendo-Villarin, and D.C. Hay Pluripotent stem cell-derived hepatocytes: potential and challenges in pharmacology Annu. Rev. Pharmacol. Toxicol. 53 2013 147 159
33. D. Szkolnicka, S.L. Farnworth, B. Lucendo-Villarin, C. Storck, W. Zhou, J.P. Iredale, O. Flint, and D.C. Hay Accurate prediction of drug-induced liver injury using stem cell-derived populations Stem Cells Transl Med 3 2014 141 148
34. O. Takeuchi, and S. Akira Innate immunity to virus infection Immunol. Rev. 227 2009 75 86
35. H.S. Te, and D.M. Jensen Epidemiology of hepatitis B and C viruses: a global overview Clin. Liver Dis. 14 2010 1 21 vii
36. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.G. Kräusslich, and M. Mizokami et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 11 2005 791 796 (Pubitemid 41021213)
37. X. Wu, J.M. Robotham, E. Lee, S. Dalton, N.M. Kneteman, D.M. Gilbert, and H. Tang Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation PLoS Pathog. 8 2012 e1002617
38. J.D. Yang, and L.R. Roberts Hepatocellular carcinoma: A global view Nat. Rev. Gastroenterol. Hepatol. 7 2010 448 458
39. W. Zhou, Z. Hannoun, E. Jaffray, C.N. Medine, J.R. Black, S. Greenhough, L. Zhu, J.A. Ross, S. Forbes, and I. Wilmut et al. SUMOylation of HNF4α regulates protein stability and hepatocyte function J. Cell Sci. 125 2012 3630 3635